Latest Insider Transactions at Hca Healthcare, Inc. (HCA)
This section provides a real-time view of insider transactions for Hca Healthcare, Inc. (HCA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HCA Healthcare, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HCA Healthcare, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2024
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Bona fide gift
|
Direct |
349
-3.4%
|
-
|
|
Feb 09
2024
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Open market or private sale
|
Direct |
4,262
-29.37%
|
$1,304,172
$306.21 P/Share
|
|
Feb 06
2024
|
Erol R Akdamar Group President |
BUY
Bona fide gift
|
Indirect |
12,874
+18.87%
|
-
|
|
Feb 06
2024
|
Erol R Akdamar Group President |
SELL
Bona fide gift
|
Direct |
12,874
-100.0%
|
-
|
|
Feb 06
2024
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,423
-6.55%
|
$435,438
$306.82 P/Share
|
|
Feb 06
2024
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
BUY
Exercise of conversion of derivative security
|
Direct |
2,092
+8.79%
|
$361,916
$173.12 P/Share
|
|
Feb 06
2024
|
Bill B Rutherford CFO and EVP |
SELL
Open market or private sale
|
Direct |
6,000
-41.53%
|
$1,860,000
$310.63 P/Share
|
|
Feb 05
2024
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,288
-22.81%
|
$1,329,280
$310.62 P/Share
|
|
Feb 05
2024
|
Kathleen M Whalen SVP & Chief Ethics Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,550
+15.15%
|
$718,200
$84.23 P/Share
|
|
Feb 05
2024
|
Christopher F. Wyatt SVP & Controller |
SELL
Open market or private sale
|
Direct |
4,000
-9.67%
|
$1,248,000
$312.42 P/Share
|
|
Feb 05
2024
|
Bill B Rutherford CFO and EVP |
BUY
Bona fide gift
|
Indirect |
1,194
+5.68%
|
-
|
|
Feb 05
2024
|
Bill B Rutherford CFO and EVP |
SELL
Bona fide gift
|
Direct |
1,369
-4.37%
|
-
|
|
Feb 05
2024
|
Sammie S Mosier SVP & Chief Nurse Executive |
SELL
Open market or private sale
|
Direct |
1,645
-17.71%
|
$513,240
$312.0 P/Share
|
|
Feb 03
2024
|
Chad J Wasserman SVP and CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
38
-9.11%
|
$11,742
$309.42 P/Share
|
|
Feb 03
2024
|
Chad J Wasserman SVP and CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
127
+23.35%
|
-
|
|
Feb 03
2024
|
Sammie S Mosier SVP & Chief Nurse Executive |
SELL
Payment of exercise price or tax liability
|
Direct |
34
-0.36%
|
$10,506
$309.42 P/Share
|
|
Feb 03
2024
|
Sammie S Mosier SVP & Chief Nurse Executive |
BUY
Exercise of conversion of derivative security
|
Direct |
137
+1.45%
|
-
|
|
Feb 02
2024
|
Bill B Rutherford CFO and EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
9,652
-37.9%
|
$2,982,468
$309.42 P/Share
|
|
Feb 02
2024
|
Bill B Rutherford CFO and EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
19,100
+42.85%
|
$1,317,900
$69.58 P/Share
|
|
Feb 02
2024
|
Chad J Wasserman SVP and CIO |
SELL
Open market or private sale
|
Direct |
652
-69.21%
|
$203,424
$312.04 P/Share
|
|
Feb 02
2024
|
Sammie S Mosier SVP & Chief Nurse Executive |
SELL
Payment of exercise price or tax liability
|
Direct |
5,127
-35.82%
|
$1,584,243
$309.42 P/Share
|
|
Feb 02
2024
|
Sammie S Mosier SVP & Chief Nurse Executive |
BUY
Exercise of conversion of derivative security
|
Direct |
6,298
+11.63%
|
$1,423,348
$226.21 P/Share
|
|
Feb 01
2024
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Payment of exercise price or tax liability
|
Direct |
9,268
-32.08%
|
$2,910,152
$314.66 P/Share
|
|
Feb 01
2024
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
BUY
Exercise of conversion of derivative security
|
Direct |
12,994
+11.62%
|
$2,624,788
$202.07 P/Share
|
|
Jan 31
2024
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Open market or private sale
|
Direct |
3,861
-19.54%
|
$1,185,327
$307.0 P/Share
|
|
Jan 31
2024
|
Christopher F. Wyatt SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
6,376
-13.35%
|
$1,938,304
$304.9 P/Share
|
|
Jan 31
2024
|
Christopher F. Wyatt SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
11,680
+11.16%
|
$1,062,880
$91.56 P/Share
|
|
Jan 31
2024
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
3,200
-11.38%
|
$979,200
$306.79 P/Share
|
|
Jan 31
2024
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Bona fide gift
|
Direct |
728
-2.52%
|
-
|
|
Jan 29
2024
|
Sammie S Mosier SVP & Chief Nurse Executive |
SELL
Payment of exercise price or tax liability
|
Direct |
96
-1.18%
|
$27,456
$286.73 P/Share
|
|
Jan 29
2024
|
Sammie S Mosier SVP & Chief Nurse Executive |
BUY
Exercise of conversion of derivative security
|
Direct |
323
+3.83%
|
-
|
|
Jan 29
2024
|
Richard A Hammett Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
164
-1.14%
|
$46,904
$286.73 P/Share
|
|
Jan 29
2024
|
Richard A Hammett Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
600
+4.01%
|
-
|
|
Jan 28
2024
|
Michael R Mc Alevey EVP - Chief Legal & Admin Off |
SELL
Payment of exercise price or tax liability
|
Direct |
489
-10.86%
|
$138,387
$283.43 P/Share
|
|
Jan 28
2024
|
Michael R Mc Alevey EVP - Chief Legal & Admin Off |
BUY
Exercise of conversion of derivative security
|
Direct |
1,940
+30.12%
|
-
|
|
Nov 14
2023
|
Joseph A Sowell Iii SVP; Chief Development Officer |
BUY
Bona fide gift
|
Indirect |
34,930
+50.0%
|
-
|
|
Nov 14
2023
|
Joseph A Sowell Iii SVP; Chief Development Officer |
SELL
Bona fide gift
|
Direct |
5,159
-100.0%
|
-
|
|
Nov 14
2023
|
Joseph A Sowell Iii SVP; Chief Development Officer |
SELL
Bona fide gift
|
Indirect |
29,771
-50.0%
|
-
|
|
Nov 13
2023
|
Erol R Akdamar Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
13,951
-52.01%
|
$3,194,779
$229.99 P/Share
|
|
Nov 13
2023
|
Erol R Akdamar Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
26,825
+50.0%
|
$1,260,775
$47.97 P/Share
|
|
Nov 10
2023
|
Phillip G Billington SVP-Internal Audit Services |
SELL
Payment of exercise price or tax liability
|
Direct |
6,237
-11.12%
|
$1,446,984
$232.82 P/Share
|
|
Nov 10
2023
|
Phillip G Billington SVP-Internal Audit Services |
BUY
Exercise of conversion of derivative security
|
Direct |
12,025
+17.65%
|
$565,175
$47.97 P/Share
|
|
Nov 10
2023
|
Joseph A Sowell Iii SVP; Chief Development Officer |
BUY
Bona fide gift
|
Indirect |
29,771
+50.0%
|
-
|
|
Nov 10
2023
|
Joseph A Sowell Iii SVP; Chief Development Officer |
SELL
Bona fide gift
|
Indirect |
29,771
-100.0%
|
-
|
|
Aug 14
2023
|
Bill B Rutherford CFO and EVP |
BUY
Bona fide gift
|
Indirect |
90,000
+42.74%
|
-
|
|
Aug 14
2023
|
Bill B Rutherford CFO and EVP |
SELL
Bona fide gift
|
Indirect |
49,500
-100.0%
|
-
|
|
Aug 14
2023
|
Bill B Rutherford CFO and EVP |
SELL
Bona fide gift
|
Direct |
40,500
-86.41%
|
-
|
|
Aug 14
2023
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Open market or private sale
|
Direct |
5,204
-20.85%
|
$1,399,876
$269.12 P/Share
|
|
Aug 11
2023
|
Jeffrey E. Cohen SVP-Government Relations |
SELL
Open market or private sale
|
Direct |
1,500
-25.36%
|
$405,000
$270.0 P/Share
|
|
Aug 04
2023
|
Mike A Marks EVP and CFO |
SELL
Bona fide gift
|
Direct |
205
-82.0%
|
-
|